These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12113029)

  • 1. Therapeutic advances in the management of metastatic colorectal cancer.
    Freyer G; Ligneau B; Kraft D; Descos L; Trillet-Lenoir V
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):236-46. PubMed ID: 12113029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
    Grivicich I; Mans DR; Peters GJ; Schwartsmann G
    Braz J Med Biol Res; 2001 Sep; 34(9):1087-103. PubMed ID: 11514832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy for colorectal cancers].
    Lièvre A; Mitry E
    J Chir (Paris); 2003 Feb; 140(1):52-5. PubMed ID: 12709655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer.
    Holen KD; Saltz LB
    Lancet Oncol; 2001 May; 2(5):290-7. PubMed ID: 11905784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing palliative treatment of metastatic colorectal cancer in the era of biologic therapy.
    Grothey A; Marshall JL
    Oncology (Williston Park); 2007 Apr; 21(5):553-64, 566; discussion 566-8, 577-8. PubMed ID: 17536342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer?
    Nipp RD; Ryan DP
    Oncologist; 2015 Mar; 20(3):236-8. PubMed ID: 25660156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
    Oestreicher P
    ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
    [No Abstract]   [Full Text] [Related]  

  • 10. [Systemic treatment of colorectal cancers--factual standards and perspectives].
    Miron L
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):752-8. PubMed ID: 14756014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.
    Dy GK; Krook JE; Green EM; Sargent DJ; Delaunoit T; Morton RF; Fuchs CS; Ramanathan RK; Williamson SK; Findlay BP; Pockaj BA; Sticca RP; Alberts SR; Pitot HC; Goldberg RM;
    J Clin Oncol; 2007 Aug; 25(23):3469-74. PubMed ID: 17687151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.
    Cassidy J
    Clin Adv Hematol Oncol; 2008 May; 6(5):360-1. PubMed ID: 18516025
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study).
    Hebbar M; Tournigand C; Lledo G; Mabro M; André T; Louvet C; Aparicio T; Flesch M; Varette C; de Gramont A;
    Cancer Invest; 2006 Mar; 24(2):154-9. PubMed ID: 16537184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer.
    Jensen NF; Smith DH; Nygård SB; Rømer MU; Nielsen KV; Brünner N
    Scand J Gastroenterol; 2012 Mar; 47(3):340-55. PubMed ID: 22181013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for metastatic colorectal cancer.
    Drug Ther Bull; 2002 Jul; 40(7):49-52. PubMed ID: 12154490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetuximab: new drug. Metastatic colorectal cancer: an inappropriate evaluation.
    Prescrire Int; 2005 Dec; 14(80):215-7. PubMed ID: 16400742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line therapy in colorectal cancer.
    Berlin J
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):21-6. PubMed ID: 11204658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction therapy in patients with metastatic colorectal cancer.
    Venook AP
    Semin Oncol; 2003 Aug; 30(4 Suppl 12):25-9. PubMed ID: 14508724
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.
    Folprecht G; Köhne CH
    Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer.
    Reina JJ; Aparicio J; Salvador J; Pica JM; Rueda A; Lorenzo A; de la Puente CG; Borrega P; Moreno-Nogueira JA
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):339-45. PubMed ID: 12851783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.